Patrick O'Brien, General Counsel at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 30,000 shares at $24.88 ($746K) on 2019-05-28, disclosed to the SEC on 2019-05-29.
Open-market sale of $746k ARWR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GLRE | SELL | 2025-05-14 | $267K | — | Filing → |
| ARWR | SELL | 2025-01-07 | $1.3M | — | Filing → |
| ARWR | SELL | 2024-01-05 | $1.9M | — | Filing → |